Nephros (NEPH) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.19% |
| Dec 31, 2025 | -8.11% |
| Sep 30, 2025 | -2.64% |
| Jun 30, 2025 | -4.80% |
| Mar 31, 2025 | -7.39% |
| Dec 31, 2024 | 2.23% |
| Sep 30, 2024 | 3.99% |
| Jun 30, 2024 | 3.09% |
| Mar 31, 2024 | 7.86% |
| Dec 31, 2023 | 4.22% |
| Sep 30, 2023 | 16.22% |
| Jun 30, 2023 | 13.99% |
| Mar 31, 2023 | 36.19% |
| Dec 31, 2022 | 35.42% |
| Sep 30, 2022 | 104.94% |
| Jun 30, 2022 | 73.98% |
| Mar 31, 2022 | 57.70% |
| Dec 31, 2021 | 85.75% |
| Sep 30, 2021 | 65.98% |
| Jun 30, 2021 | 55.05% |
| Mar 31, 2021 | 50.79% |
| Dec 31, 2020 | 50.98% |
| Sep 30, 2020 | 32.59% |
| Jun 30, 2020 | 32.41% |
| Mar 31, 2020 | 35.22% |
| Dec 31, 2019 | 27.38% |
| Sep 30, 2019 | 80.98% |
| Jun 30, 2019 | 99.38% |
| Mar 31, 2019 | 48.89% |
| Dec 31, 2018 | 30.80% |
| Sep 30, 2018 | 56.73% |
| Jun 30, 2018 | 39.84% |
| Mar 31, 2018 | 25.55% |
| Dec 31, 2017 | 39.47% |
| Sep 30, 2017 | -3.88% |
| Jun 30, 2017 | -2.68% |
| Mar 31, 2017 | 5.85% |
| Dec 31, 2016 | -14.04% |
| Sep 30, 2016 | -8.06% |
| Jun 30, 2016 | -5.57% |
| Dec 31, 2015 | -85.11% |